Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navitoclax extension in CLL
NCT01557777Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of navitoclax in chronic lymphocytic leukemia (CLL), sponsored by AbbVie Inc.. Started Jun 2012; status: completed.
02
Drugs
navitoclax
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01557777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01557777.